Stephen Cook, MD
Cardiovascular Disease · Vancouver, WANPI 1801894878
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 61.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $12,788 and has fallen 97.9% since, to $271 in 2024. Among cardiovascular disease clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $317.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Abbott$5K
- Asahi Intecc USA, Inc.$105
- Abiomed$92
- Philips North America LLC$22
- Ablative Solutions, Inc.$18
- plus $27 from 2 others
What the payments were for
- Consulting fees$4,50033%
- Speaking & faculty fees$6,62548%
- Travel & lodging$1,35610%
- Food & beverage$1,1939%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $8,334 |
| Abbott | 8 | $5,074 |
| Asahi Intecc USA, Inc. | 1 | $105 |
| Abiomed | 6 | $92 |
| Philips North America LLC | 1 | $22 |
| Ablative Solutions, Inc. | 1 | $18 |
| W. L. Gore & Associates, Inc. | 1 | $16 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CROSSBOSS$7,099
- Xience V coronary stent system$4,835
- GENERAL - THERAPIES$622
- ASAHI PTCA Guide Wire$105
- XIENCE SIERRA$105
How this compares
$13,673 in reported general payments places this provider in the 90th percentile of 370 cardiovascular disease providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Vancouver
- Joshua GrantVancouver$23K
- Stuart JacobsonVancouver$13K
- James ReissVancouver$11K
- Nashwa AbdulsalamVancouver$5K
- Robert BersinBellevue$657K
- Mariko HarperSeattle$246K
- Gary OppenheimSeattle$153K
- Kelley BranchSeattle$103K
- Munish Kumar KannabhiranRichland$85K
- Erik WissnerSeattle$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.